Clarithromycin-induced acute liver injury in a patient with positive

Helicobacter pylori clarithromycin drug-induced liver injury

Journal

Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 12 06 2023
accepted: 27 07 2023
medline: 4 9 2023
pubmed: 4 9 2023
entrez: 4 9 2023
Statut: epublish

Résumé

While 14-day triple therapy with clarithromycin is a common approach for eradicating We present the case of a 34-year-old male who presented to the emergency department with severe vomiting and abdominal pain. Subsequent evaluation revealed that the patient had developed drug-induced liver injury (DILI). DILI can cause acute hepatocellular or cholestatic damage, and chronic injury can lead to hepatocellular, cholestatic, vascular, or neoplastic manifestations. Clinicians should exercise caution and be alert to the potential hepatotoxic effects of medications, especially when initiating triple therapy for

Identifiants

pubmed: 37663679
doi: 10.1097/MS9.0000000000001135
pii: AMSU-D-23-01273
pmc: PMC10473337
doi:

Types de publication

Case Reports

Langues

eng

Pagination

4629-4632

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Références

Curr Treat Options Gastroenterol. 2020;18(3):476-487
pubmed: 32837180
J Hepatobiliary Pancreat Surg. 2007;14(1):52-8
pubmed: 17252297
Minerva Med. 2021 Apr;112(2):281-287
pubmed: 32700868
Clin Gastroenterol Hepatol. 2014 Feb;12(2):177-86.e3; Discussion e12-3
pubmed: 23751282
World J Gastroenterol. 2018 Apr 7;24(13):1373-1385
pubmed: 29632419
Int J Surg. 2020 Dec;84:226-230
pubmed: 33181358
Antimicrob Agents Chemother. 2008 Sep;52(9):3465-6
pubmed: 18606842
Liver Int. 2018 Feb;38(2):198-209
pubmed: 28865179
N Engl J Med. 2002 Oct 10;347(15):1175-86
pubmed: 12374879
Am J Gastroenterol. 2021 May 1;116(5):878-898
pubmed: 33929376
Clin Microbiol Rev. 2007 Apr;20(2):280-322
pubmed: 17428887
Pharm Res. 2019 Feb 7;36(3):48
pubmed: 30734107
Antimicrob Agents Chemother. 1996 Feb;40(2):477-80
pubmed: 8834903
World J Gastroenterol. 2014 Aug 7;20(29):9898-911
pubmed: 25110420
Case Reports Hepatol. 2020 Feb 18;2020:2135239
pubmed: 32148980
J Korean Surg Soc. 2012 Aug;83(2):97-101
pubmed: 22880184

Auteurs

Nava Raj Sharma (NR)

Manipal College of Medical Sciences, Pokhara.

Abhishesh Wagle (A)

Institute of Medicine, Tribhuvan University, Maharajgunj.

Manoj Bist (M)

Lumbini Medical College, Palpa.

Bishal Panthi (B)

Manipal College of Medical Sciences, Pokhara.

Ritu Pokhrel Dahal (R)

Kathmandu Medical College, Kathmandu.

Rajesh Rokaya (R)

College of Medical Science, Bharatpur, Nepal.

Rayana Shrestha (R)

Institute of Medicine, Tribhuvan University, Maharajgunj.

Madalasa Pokhrel (M)

Montefiore New Rochelle Hospital, New Rochelle, New York, USA.

Classifications MeSH